medtechdive32m
Boston Scientific closes its year of PFA on a high note
Farapulse, Boston Scientific’s pulsed field ablation product, fueled year-over-year growth of nearly 171% in the fourth ...
FiercePharma2h
With recent launches and more to come, Amgen's biosimilar business is trending up
After recent launches of biosimilar versions of Eylea and Stelara, Amgen projects its biosimilar sales will reach $4 billion ...
FierceBiotech2h
Boston Scientific clocks over $1B in Farapulse revenue for the afib therapy’s first year
Boston Scientific apparently knows a good bet when it sees one. | That includes treating more than 200,000 patients with the ...
pharmaphorum8h
Obesity and the endoscopy space: Innovative, minimally invasive weight loss
Factors contributing to the ramifications of this disease as it stands include the socio-economic: overweight and obesity ...
Area congressman part of older adult health screen bill
A congressman who serves the Piedmont Triad is part of a bipartisan campaign in Congress to expand the scope of cancer screenings for older adults. Rep. Richard Hudson, R-9th District, is a cosponsor ...
Hosted on MSN16h
MAIA’s lung cancer therapy 99% more likely to improve OS over chemo alone
A treatment for patients living with advanced non-small cell lung cancer (NSCLC) who failed two or more standard-of-care (SOC ...
Heart health at risk for new mothers of twins, study suggests
New moms who just have had twins run a high risk of heart disease in the next weeks and months, a new study suggests.